Business news

Revenues at cannabis startups surge as demand begins to outstrip supply

"We anticipate this dynamic to continue for some time," said one CEO

The legal cannabis farm set to supply medical cannabis to the UK

This is one of the cannabis farms set to supply cannabis-based products for medicinal purposes to the UK. Groundbreaking legislation that came into effect on November 1 means that specialist UK doctors are now able to prescribe cannabis-based products

Bod teams up with Chemist Warehouse to distribute medicinal cannabis products

After securing its first prescription approval for MediCabilis in October, Bod (ASX: BDA) has announced a partnership with a leading pharmacy chain to distribute its hero product

Asia plants seeds for medical cannabis market

Thailand, Singapore and China pursue research into health care uses

Creso Pharma launches medical cannabis pain lozenge in Brazil

Medical cannabis developer Creso Pharma (ASX: CPH) has announced yet another foray into new markets following the launch of its cannaQIX 50 lozenge in South America’s most populous country, Brazil

A.T. Kearney Logo. (PRNewsFoto/A.T. Kearney)

76% of North American consumers would try a legal cannabis therapeutic product

More than three-quarters would try medicinal cannabis products and about half would try cannabis-enhanced consumer products such as snack foods (55 percent)

Medicinal cannabis research company intends to list on NZX

In a first for New Zealand, medicinal cannabis research company Cannasouth has announced it will make an application to list its shares on the NZX Main Board through an initial public offering (IPO) during the second calendar quarter of 2019

Cannabis is officially legal in Canada. Now what?

The cannabis industry has promise but the Canadian market is not nearly enough to sustain the outsized valuations of a string of cannabis firms. For that to happen, the legalisation push must include the entire U.S.

Organigram to take 25% stake in German cannabis company

Organigram announces definitive agreement to acquire 25% of alpha-cannabis® Pharma GmbH. Presence in Germany extends company’s commitment to international expansion

Medical cannabis producer and retailer Medmen to buy Pharmacann for $682m

The largest takeover deal in the American cannabis industry has been signed after Medmen, a medical cannabis producer and retailer, agreed to buy Pharmacann, its rival, for $682 million